Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
Abnormalities of chromosome 7q are common in myeloid malignancies, but no specific target genes have yet been identified. Here, we describe the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy. Screening of a total of 614 individuals with myeloid disord...
Autors principals: | Ernst, T, Chase, A, Score, J, Hidalgo-Curtis, C, Bryant, C, Jones, A, Waghorn, K, Zoi, K, Ross, F, Reiter, A, Hochhaus, A, Drexler, H, Duncombe, A, Cervantes, F, Oscier, D, Boultwood, J, Grand, F, Cross, N |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2010
|
Ítems similars
-
Inactivating mutations of the histone methyltransferase EZH2 in myeloid disorders
per: Ernst, T, et al.
Publicat: (2010) -
INACTIVATING MUTATIONS OF THE HISTONE METHYLTRANSFERASE EZH2 ARE ASSOCIATED WITH CHROMOSOME 7 ABNORMALITIES IN MYELOID DISORDERS
per: Ernst, T, et al.
Publicat: (2010) -
Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
per: Thomas Ernst, et al.
Publicat: (2010-09-01) -
EZH2 in Myeloid Malignancies
per: Jenny Rinke, et al.
Publicat: (2020-07-01) -
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
per: Su, I-hsin, et al.
Publicat: (2013)